CIN 3
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years (NCT04895020) | Shanghai Bovax Biotechnology Co., Ltd. | 2021-05-28 |
| Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT03676101) | Shanghai Bovax Biotechnology Co., Ltd. | 2018-10-10 |
| Natural History of HPV From Infection to Neoplasia in Adolescents and Young Women (NCT01366742) | University of California, Los Angeles | 1987-12-01 |
Track CIN 3 automatically
Every clearance here is in the API, with alerts when new ones post.